Company page

Repligen Corporation

Repligen Corporation, trading under the ticker RGEN, is a publicly traded company based in the United States with a market capitalization of approximately $7.45 billion. The company specializes in bioprocessing technologies and solutions for the life sciences industry. Repligen focuses on enhancing the efficiency and productivity of biopharmaceutical manufacturing processes.